GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

NCT06379113 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Neoplasms
Atypical Endometrial Hyperplasia
Progesterone Resistance
Obesity

Interventions

DRUG: GnRH antagonist
DRUG: Letrozole 2.5mg

Sponsor

Xiaojun Chen